Retinal haemodynamics in individuals with well-controlled type 1 diabetes
Abnormalities in retinal haemodynamics have been reported in patients with type 1 diabetes in advance of clinical retinopathy. These abnormalities could therefore be useful as early markers or surrogate endpoints for studying the microangiopathy. Since the DCCT, the increased focus on good glycaemic control is changing the natural history of diabetic retinopathy. Based on this, the aim of this study was to investigate whether patients with type 1 diabetes treated entirely or mostly in the post-DCCT era and tested in the absence of confounding factors show retinal haemodynamic abnormalities.
We measured retinal haemodynamics by laser Doppler flowmetry in 33 type 1 diabetic individuals with no or minimal retinopathy (age 30 ± 7 years, duration of diabetes 8.8 ± 4.6 years, 9% showing microaneurysms), and 31 age- and sex-matched non-diabetic controls. The study participants were not taking vasoactive medications, and blood glucose at the time of haemodynamic measurements was required to be between 3.8 and 11.1 mmol/l.
HbA1c was 7.5 ± 1.2% and blood glucose 7.7 ± 2.8 mmol/l in these type 1 diabetic individuals, indicating relatively good glycaemic control. Retinal blood speed, arterial diameter and blood flow were not different between the diabetic individuals and the matched controls.
Type 1 diabetic patients with no or minimal retinopathy who maintain relatively good glycaemic control do not show abnormalities of the retinal circulation at steady state, even after several years of diabetes. In such patients it may be necessary to test the vascular response to challenges to uncover any subtle abnormalities of the retinal vessels.
- Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986 CrossRef
- Guan K, Hudson C, Wong T et al (2006) Retinal hemodynamics in early macular edema. Diabetes 55:813–818 CrossRef
- Feke GT, Buzney SM, Ogasawara H et al (1994) Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35:2968–2975
- Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell S-E (1997) Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 124:433–446
- Wolf S, Arend O, Toonen H, Bertram B, Jung F, Reim M (1991) Retinal capillary blood flow measurement with a scanning laser ophthalmoscope. Ophthalmology 98:996–1000
- Kawagishi T, Nishizawa Y, Emoto M et al (1995) Impaired retinal artery blood flow in IDDM patients before clinical manifestations of diabetic retinopathy. Diabetes Care 18:1544–1549 CrossRef
- Bursell S-E, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA (1996) Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. A video fluorescein angiography study. Invest Ophthalmol Vis Sci 37:886–897
- Yoshida A, Feke GT, Mori F et al (2003) Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol 135:356–361 CrossRef
- Gilmore ED, Hudson C, Nrusimhadevara RK et al (2007) Retinal arteriolar diameter, blood velocity, and blood flow response to an isocapnic hyperoxic provocation in early sight-threatening diabetic retinopathy. Invest Ophthalmol Vis Sci 48:1744–1750 CrossRef
- Trick GL, Edwards P, Desai U, Berkowitz BA (2006) Early supernormal retinal oxygenation response in patients with diabetes. Invest Ophthalmol Vis Sci 47:1612–1619 CrossRef
- Retinal haemodynamics in individuals with well-controlled type 1 diabetes
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Volume 51, Issue 2 , pp 361-364
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Diabetic retinopathy
- Retinal blood flow
- Retinal circulation
- Type 1 diabetes
- Industry Sectors
- Author Affiliations
- 1. Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA
- 2. Schepens Retina Associates Foundation, Harvard Medical School, Boston, MA, USA
- 3. Diabetes Center and Department of Medicine at the Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- 4. Division of Preventive Medicine and Department of Medicine at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA